Technical Analysis

Global shares stepped back on Wednesday as soft U.S. retail sales increase worries that rising coronavirus cases could stifle a still fragile economic recovery, dampening the euphoria from vaccine trial breakthroughs.

US stocks are set to open slightly lower, retracing some - but by no means all - of Monday’s surge that took both the Dow Jones and S&P 500 to new record highs.

December will be an epic month for Tesla. Possibly, accompanied by an epic price growth.

The vaccine news helped the risk-friendly Australian dollar, which climbed to a one-week high against its US counterpart.

The Australian economy gives a good recovery report. That may push the AUD even further. Read and discover.

Global stocks eyed a fresh record high on Monday as signs of economic recovery in Asia, recent strong corporate earnings, and hopes of a COVID-19 vaccine bolstered investor sentiment.

Asian equities hit a record high on Monday as investors set aside fears about rising coronavirus cases and bought stocks, cheered by data showing a robust recovery in China and Japan. There are just mountains of cash sitting on the sidelines and big hedge funds know it.

U.S. stock markets are indicated to open higher on Friday at the end of a topsy-turvy week in which the initial euphoria on finding an effective vaccine against Covid-19 has buckled under the weight of the bleak short-term outlook.

Asian equity markets weakened on spill-over selling from Wall Street; Hong Kong lagged. Looking ahead, highlights from macroeconomic calendar include Eurozone Employment and GDP (Flash), US University of Michigan, Fed's Williams and Bullard speeches.

TRY recovered much of its value against the USD recently. Will the November 19 meeting of the Turkish Central Bank continue this recovery?

The global rally in stocks on the back of Pfizer’s vaccine news ground to a halt, as markets took on board the near-term challenges of a still-potent coronavirus

What's the strategic outlook for EUR/GBP? Read, and you'll see.